Aflac Inc (AFL)

Currency in USD
100.82
-0.06(-0.06%)
Closed·
After Hours
100.50-0.32(-0.32%)
·
AFL Scorecard
Full Analysis
Management has been aggressively buying back shares
Earnings results expected in 6 days
Fair Value
Day's Range
100.59102.08
52 wk Range
94.87115.50
Key Statistics
Prev. Close
100.82
Open
101.53
Day's Range
100.59-102.08
52 wk Range
94.87-115.5
Volume
2M
Average Volume (3m)
2.29M
1-Year Change
6.65%
Book Value / Share
48.25
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
AFL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
107.23
Upside
+6.36%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 41 consecutive years

Aflac Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Aflac Inc Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. The Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company sells its products through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is based in Columbus, Georgia.

Industry
Insurance
Sector
Financial
Employees
12694

Aflac Inc Earnings Call Summary for Q1/2025

  • Q1 2025 EPS of $1.66 missed $1.68 forecast; revenue of $3.4B fell short of $4.26B expectation, causing 0.62% stock dip
  • U.S. net earned premiums grew 1.8%, while Japan saw 5% decline; company repurchased $900M in shares
  • New product launches in Japan aim to strengthen market position; 2025 sales expected to surpass 2024 levels
  • CEO emphasizes role as 'partner in health' and balance of financial strength with tactical capital deployment
  • Risks include declining Japan premiums, increased expense ratios, and competitive pressures in Japanese insurance market
Last Updated: 01/05/2025, 14:20
Read Full Transcript

Compare AFL to Peers and Sector

Metrics to compare
AFL
Peers
Sector
Relationship
P/E Ratio
15.2x11.0x9.6x
PEG Ratio
−0.520.420.03
Price/Book
2.1x1.7x1.0x
Price / LTM Sales
3.2x1.1x2.9x
Upside (Analyst Target)
4.2%8.5%11.2%
Fair Value Upside
Unlock−4.2%1.9%Unlock

Analyst Ratings

3 Buy
8 Hold
2 Sell
Ratings:
13 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 107.23
(+6.36% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.47%
Dividend Yield
2.30%
Industry Median 3.27%
Annualised payout
2.32
Paid quarterly
5-Years Growth
+13.80%
Growth Streak

Earnings

Latest Release
May 07, 2025
EPS / Forecast
0.05 / 1.68
Revenue / Forecast
3.40B / 4.26B
EPS Revisions
Last 90 days

AFL Income Statement

People Also Watch

191.22
ABBV
+1.43%
147.61
EMR
-1.25%
563.06
ROP
+0.72%
222.68
CTAS
+1.04%
69.38
KO
+1.89%

FAQ

What Stock Exchange Does Aflac Trade On?

Aflac is listed and trades on the New York Stock Exchange stock exchange.

What Is the Stock Symbol for Aflac?

The stock symbol for Aflac is "AFL."

What Is the Aflac Market Cap?

As of today, Aflac market cap is 54.51B.

What Is Aflac's Earnings Per Share (TTM)?

The Aflac EPS (TTM) is 6.47.

When Is the Next Aflac Earnings Date?

Aflac will release its next earnings report on 04 Aug 2025.

From a Technical Analysis Perspective, Is AFL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Aflac Stock Split?

Aflac has split 13 times.

How Many Employees Does Aflac Have?

Aflac has 12694 employees.

What is the current trading status of Aflac (AFL)?

As of 30 Jul 2025, Aflac (AFL) is trading at a price of 100.82, with a previous close of 100.82. The stock has fluctuated within a day range of 100.59 to 102.08, while its 52-week range spans from 94.87 to 115.50.

What Is Aflac (AFL) Price Target According to Analysts?

The average 12-month price target for Aflac is USD107.23077, with a high estimate of USD127 and a low estimate of USD98. 3 analysts recommend buying the stock, while 2 suggest selling, leading to an overall rating of Neutral. The stock has an +6.36% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.